Recurrent Pregnancy Loss Clinical Trial
Official title:
Meditation and Mindfulness for Recurrent Pregnancy Loss
In the Danish Recurrent Pregnancy Loss Unit in Rigshospitalet in Copenhagen recurrent
pregnancy loss (RPL) is defined as three og more consecutive pregnancy losses in accordance
with current European guidelines.
RPL affects approximately 3% of couples trying to achieve parenthood. Most cases of RPL are
unexplained and have no effective treatment to improve the chance of a live birth.
42% of the women referred to RPL Unit in Rigshospitalet has a high stress level where as it's
22% in the background population trying to achieve parenthood. It's also known that 8,8 % of
RPL patients have a depression at referral where as it's 2,2 % in the background population
trying to achieve parenthood.
The study is a RCT including 62 patients - 31 in each arm. One arm will be taught in
meditation and mindfulness three courses over a 7 week period. This group will also do
meditation every day for 7 weeks. The other arm will have no intervention.
This study will investigate if a 7 weeks course in meditation and mindfulness is a useful
tool to reduce stress and the psychological consequences for women and their partner treated
in RPL Unit in Rigshospitalet, Copenhagen. Furthermore this study will investigate if there's
a marital benefit such as reinforcement in their relationsship from practicing meditation and
mindfulness.
There is no previous study that has investigated meditation and mindfulness for RPL.
This study has the potential to establish mental health support as a supplement to the
medical and clinical treatment for RPL patients.
The loss of a desired pregnancy is a significant negative life event associated with grief
comparable to the grief after a peri- or neonatal death. Recurrent pregnancy loss (RPL)
defined as 3 or more pregnancy losses affects approximately 3% of couples trying to have
children. Most cases of RPL are unexplained and have no effective treatment to improve the
chance of a live birth.
42% of the women referred to RPL Unit in Rigshospitalet has a high stress level where as it's
22% in the background population trying to achieve parenthood. It's also known that 8,8% of
RPL patients have a depression at referral where as it's 2,2 % in the background population
trying to achieve parenthood.
This study will investigate if a 7 weeks course in meditation and mindfulness is a useful
tool to reduce stress and the psychological consequences for women and their partner treated
in RPL Unit in Rigshospitalet, Copenhagen.
Furthermore this study will investigate if there's a marital benefit from practicing
meditation and mindfulness. The investigators will use four different scales to measure the
participants stress, depression, marital benefit and fertility stress. Also the investigators
will measure the participants before and after the intervention and 12 months after.
All participants will have to complete:
1. Major Depression Index, a validated self-rating depression scale, which is used both
clinically and in epidemiological studie. The 6-point Likert scale ranges from 0 (no
depression) to 50 (extreme depression).
2. Perceived Stress Scale, which is a validated 10-item-self-reporting scale for stress
symptoms. The 5 point Likert scale ranges from 0 (no stress) to 40 (extreme stress).
3. The COMPI Fertility Problem Stress Scale, a validated scale measuring the impact of RPL
on the woman and her interpersonal relationships.
4. The COMPI Marital Benefit Scale measuring if RPL has reinforced the couples
mariage/relationship.
The investigators assume that meditation and mindfulness can improve the quality of life for
the RPL patients and their coping strategies. It's the investigators purpose to contribute
with new knowledge in this area for current and future patients.
The RPL Unit in Rigshospitalet doesn't have any psychological support apart from ordinary
attention from the nurses. This study has the potential to establish mental health support as
a supplement to the medical and clinical treatment for RPL patients, which is in high demand.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04718233 -
Effect of Sildenafil Citrate on Mid Luteal Phase Uterine Artery Blood Flow in Patients With Recurrent Pregnancy Loss
|
Phase 2 | |
Recruiting |
NCT01946945 -
Comparison of Standard ART Practice vs. Trophectoderm Biopsy and Whole Chromosome Analysis
|
Phase 2 | |
Completed |
NCT02572154 -
Sperm DNA Fragmentation in Recurrent Pregnancy Loss
|
N/A | |
Completed |
NCT03174951 -
Immunomodulatory Effects of IVIg on Pregnancy Rate of Patient With Recurrent Pregnancy Loss
|
Phase 2 | |
Recruiting |
NCT05444283 -
Genomic Predictors of Recurrent Pregnancy Loss
|
||
Active, not recruiting |
NCT04621773 -
Live Birth Rate in Patients With Unexplained Recurrent Pregnancy Loss
|
||
Recruiting |
NCT02990403 -
The Novel Immunomodulatory and Anticoagulant Therapies for Recurrent Pregnancy Loss
|
Phase 4 | |
Recruiting |
NCT02990390 -
The Epidemiology of Recurrent Spontaneous Abortion Associated With Thrombophilla
|
N/A | |
Not yet recruiting |
NCT05612620 -
Elucidating the Microbiome in Patients With Recurrent Pregnancy Loss
|
||
Not yet recruiting |
NCT05520112 -
Treatment of Recurrent Pregnancy Loss Using Mesenchymal Stem Cells
|
Phase 1/Phase 2 | |
Suspended |
NCT04397042 -
SCUBE-1 and Carotid Intima Media Thickness in Recurrent Pregnancy Loss
|
||
Not yet recruiting |
NCT05341856 -
Uterine Artery Doppler Changes After Vaginal Administration of Isosorbide Mononitrate In Patients With URPL
|
Early Phase 1 | |
Recruiting |
NCT06007560 -
Aerobe Cycling Training in Women With Unexplained Recurrent Pregnancy Loss
|
N/A | |
Completed |
NCT02386384 -
TNFα and MFG-E8: Novel Biomarkers to Predict Implantation Failure
|
N/A | |
Recruiting |
NCT01635426 -
Aspirin Versus Clopidogrel Effect on Uterine Blood Flow in Women With Unexplained Recurrent Miscarriages
|
Phase 2/Phase 3 | |
Suspended |
NCT01546350 -
Preimplantation Genetic Diagnosis Using Blastocyst Biopsy and Array CGH
|
Phase 2 | |
Completed |
NCT00721591 -
Pharmacokinetics of Low Molecular Weight and Unfractionated Heparin in Pregnancy
|
N/A | |
Terminated |
NCT00564174 -
Low Molecular Weight Heparin and Aspirin in the Treatment of Recurrent Pregnancy Loss: A RCT
|
N/A | |
Completed |
NCT04455256 -
Evaluation of Endoplasmic Reticulum Stress in Patients With Recurrent Pregnancy Loss
|
||
Not yet recruiting |
NCT05237843 -
Hydroxychloroquine in Unexplained Recurrent Pregnancy Loss
|
Phase 1 |